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Introduction: Stress incontinence is a problem increasingly affecting older people. This 
discomfort has an impact on women as a greater extent. Stress urinary incontinence is 
described as involuntary leakage of urine during even minor efforts: sneezing, coughing, 
rapid gait. At the beginning inconspicuous loss of a few drops of urine is often not alarming 
for women. The problem is significant because women often go to a specialist very late and 
the reason for this is shame. Many people think that this is an accident of old age and it can’t 
be stopped. Nothing could be more wrong, it can be dealt with. 
 
Material and methods: Articles in the EBSCO database have been analysed using 
keywords: stress incontinence, problems of old age, physiotherapy in urology, older women. 
 
Results: The incidence of stress incontinence in women increases with age. The main reason 
is muscular weakness, which is caused, among other things by pregnancies and labours. 
Another reason may be hormonal disorders and genetic predisposition.  Statistics show that 
obese women are more likely to suffer from SUI. The progress of medicine and 
pharmacology is also increasingly effective in the treatment of stress urinary incontinence. 
First, after finding the problem, conservative treatment is introduced. Treatment is adapted to 
each patient individually. Age, existing diseases, weight are important factors in the process 
of treatment.  In pharmacology Duloxetine is used. The use of this drug does not completely 
eliminate the symptoms of stress urinary incontinence. Due to the possibility of side effects 
i.e. nausea, the drug is used very carefully. In recent years, physiotherapy has been highly 
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valued in the treatment of stress urinary incontinence. The most important is kinesitherapy 
here. Strengthening the pelvic floor muscles brings the most beneficial effects. Active 
exercises are supported by: electrostimulation, magnetotherapy and vibro-therapy. The final 
form of SUI treatment is surgical treatment. However, this do not always bring the expected 
results. In order to increase the effectiveness of therapy for patients with SUI, the 
interdisciplinary cooperation of the medical team should be used. Treatment of stress urinary 
incontinence primarily leads to improved quality of life for patients. 
 
Conclusions: Urinary incontinence is a social disease. Women struggle with this problem 
twice as often than men. Stress incontinence accounts for 63% of all forms of urinary 
incontinence in women in Poland. The incidence of incontinence increases with age. 
Problems with stress urinary incontinence become a reason for isolation from society. The 
patients are not aware of the treatment possibilities, which often results in late inclusion of 
treatment and rehabilitation. There is a wide range of SUI treatment options. Therefore it is 
necessary to personalise rehabilitation process to best fit to each patient. 
 





Urinary incontinence is defined as a disorder that affects urine bladder storage. 
According to ICS - International Continence Society - incontinence is any leakage of urine 
that is not controlled by a person. Among all the types of urinary incontinence, the most 
common type is stress urinary incontinence (SUI) [1, 2]. One of the reasons for this 
phenomenon is the frequent occurrence of this disease in older people. The direct cause of 
stress urinary incontinence is the weakening of the pelvic floor muscles because of the age. 
This results in urine leakage during various daily activities and physical activity, e.g. 
climbing stairs, as well as during a cough, a sudden change in body position or lifting heavy 
objects. 
It is worth remembering that there are many factors that predispose to SUI. Among 
them, three main groups are mentioned. The first of these are predisposing factors, which 
include, among others, genetic conditions and gender. Besides, the inciting factors are 
distinguished, which are related to the damage to the urinary incontinence mechanism. These 
contain a large number of births and previous abdominal operations. The last group are 
promotional factors, which feature overweight, obesity, menopause, medications and 
previous infections [1, 3]. 
Stress urinary incontinence is not a condition that is talked about quite openly and 
publicly. Often, women suffering from SUI do not admit to the problems, because they feel 
or believe that at a certain age urinary leakage is "normal". Nevertheless, stress urinary 
incontinence symptoms can impose a significant burden on the women who have them, that’s 
why there is a real need for healthcare professionals to be proactive in questioning and 
educating patients about lower urinary tract symptom [4, 5]. In the era of contemporary 
medicine, there are many ways to treat and prevent SUI, so it is worth using them. The 








Causes of stress incontinence in older women 
Age is an important factor affecting the occurrence of stress urinary incontinence 
(SUI). The frequency of this phenomenon increases with age. The main reason for the 
occurrence of SUI in older women are changes in the myofascial system. These changes 
occur with age and are caused by the pregnancies and labours. As a result, the pelvic organs 
are lowering down, as well as the ligamentous apparatus is being damaged, which disturbs 
the organ system's statics. High birth weight of a child, delivery over 24 hours and abnormal 
maternity practices, including pushing without getting full dilatation, pushing with full 
bladder may cause pelvic muscle damage. Damage to the nerves supplying the pelvic floor 
muscles may ultimately lead to urinary incontinence in old age. Appropriate support for the 
bladder neck through the pelvic floor is the correct micturition process. Disorders of this 
structure very often leads to stress urinary incontinence. Injuries and operations in the crotch 
area are the risk factors for this disease. Direct injuries of the urethra leads to scarring of the 
coil, resulting in disruption of its function [6,8,10]. 
Hormonal disorders that occur during menopause are also predisposing factors for the 
occurrence of SUI in the elderly. Decrease in estrogen levels lead to adverse changes in the 
genito-urinary system. After the period of menopause, there is a change in the connective 
tissue, precisely a change in the structure of collagen – generation of the V and VII type 
fibers. As a result of the body ageing, the bladder detrusor is being encircled with collagen, 
which makes it weaker and consequently less susceptible to spasms. Genetic predisposition 
also affects the occurrence of this disease. It is noted that the frequency increases even three 
times in first-line relatives [5,6,8,9]. 
Interestingly, the occurrence of SUI depending on the origin and race of the woman.  
It is caused by cultural differences as well as social and environmental factors. The 
occurrence of the disease is supported by obesity, it is estimated that WNTM is four times 
more common in obese women than in people with normal body mass. As a result of obesity, 
intra-abdominal pressure and intra-bladder pressure increases. Those higher pressures have a 
negative effect on the urethra, and as a result it may increase its mobility. The disturbance of 
the micturition process also occurs as a result of many diseases, including diseases of the 
central nervous system, e.g. Parkinson's disease or a multiple sclerosis. Among the risk 
factors of stress urinary incontinence specialists also mentions: smoking, chronic cough, hard 
physical work, chronic constipation [6,7,8,9]. 
 
Pathomechanism of urinary incontinence 
Urinary incontinence is not a name that uniquely describes a disease entity, but a 
symptom that arises from complex functional, structural and hormonal changes in the female 
body. Currently, the popular statement is that due to the close anatomical-functional 
relationship of the nervous and genitourinary systems, any episode of disturbance of urination 
control may have a neurogenic basis. There is a division into three groups of factors 
predisposing to the occurrence of the disease, which combine with each other and at the same 
time increase the existing risk. These are genetic, environmental and lifestyle factors. The 
next division distinguishes predisposing, triggering, decomposing and promoting factors. 
Predisposing factors include genetic, racial, neurological, anatomical and cultural factors. 
Urinary incontinence has been divided into several types by ICS [11, 12, 13]. 
            Stress urinary incontinence occurs when involuntary loss of urine occurs during an 
increase in intra-abdominal pressure. Physiological pressure increases in the abdominal 
cavity occur, for example, during coughing, sneezing or physical work. Stress urinary 
incontinence is characterized by uncontrolled outflow of small amounts of urine without 
feeling pressured [11, 12, 13]. 
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            Urgent incontinence (abbreviated as NNM) is involuntary urination under the 
influence of forced urge. Urgency is the sensation of a sudden and difficult urge to urinate. 
Patients repeatedly describe urgency as a continuous and troublesome need to use the toilet. 
NNM can be caused by two main causes: instability of the bladder or its excessive 
excitability [11, 12, 13]. 
Another type of incontinence is urinary incontinence. It is also called chronic urine 
retention in the bladder and is due to impaired detrusor contractility. Disturbed contractility 
leads to excessive bladder filling. This type of urinary incontinence is very often caused by 
drug-induced impairment of central nervous system function or diseases [11, 12, 13]. 
            Urinary incontinence caused by extrasphincteric causes is a type of disorder 
distinguished by ICS, which consists in unconscious urination through the fistula. This fistula 
bypasses the urethral mechanism, which is partially functional [11, 12, 13]. 
            The last group included: mixed and reflex urinary incontinence, bedwetting and 
continuous incontinence [11, 12, 13]. 
 
Epidemiology of urinary incontinence in women 
 According to the epidemiological data, a problem of urinary incontinence (NTM) 
affects about 10% of the human population. Due to the progressive aging of the population, 
the rate of NTM incidence increases constantly. The disease is considered to be a social 
disease (it is about more than 5% of the human population). It has a big influence at the 
quality of people’s life and their functioning during everyday activities [14,12]. 
         The incidence of NTM is two times higher in women than in men. In Poland, this 
problem affects approximately 4-6 million women, where 63% of cases is a form of stress 
incontinence, approx. 19-25% is an urgent NTM and 12-19% is a mixed form. On the other 
hand, among the population around the world, the data show about 20% of women over 40 
years old suffer from this disease [14]. 
The problem of the stress urinary incontinence affects particularly women after 
childbirth, woman in perimenopausal and women in old age. The research shows that among 
women over 30 years old, about 10-25% have problems because of this disease. In the fifth 
decade of people’s life the number of cases increases significantly. After 60 years of age it is 
about almost half of women. The urinary incontinence incidents happen in follow situations: 
sneezing or coughing, laughing, taking standing positions and going up the stairs [15,16]. 
         The involuntary urination during sexual intercourses happens to about 25% of 
women. Because of that they fear about lack of acceptance from the partner and they have a 
high psychological discomfort. Due to hygiene problems, it is necessary to use sanitary 
napkins or even diapers, to go to the toilet frequently and to fight with unpleasant smell. 
Therefore, this condition leads to a huge change in a previous people’s lifestyle [15]. 
Because of an embarrassing nature of the disease and an ignorance about treatment, about 2/3 
of the sick people hide their problem. They don’t even try to consult a doctor and it causes a 
delaying of introducing specialized treatment. All of that leads  to a people's social isolation,  
troubles in a social and professional life [16]. 
 
Pharmacological treatment of stress urinary incontinence 
Treatment of the stress urinary incontinence should focus on improving the quality of 
life of the patient. Before the implementation of pharmacotherapy, the co-occurrences of 
other diseases, use of other medicines by the patient and the risk of side effects should be 
considered [11, 17, 18, 19]. 
Estrogens and tricyclic antidepressants, applied previously in the pharmacotherapy of 
stress urinary incontinence, did not have a proven clinical effect and were associated with the 
frequent occurrence of significant side effects [20]. Currently, the only licensed drug used in 
213 
 
the treatment of SUI of which efficiency has been confirmed in randomized controlled 
clinical trials (RCTs) is Duloxetine - a serotonin-noradrenaline reuptake inhibitor (SNRI). 
Initially, this drug was only used in the treatment of depressive disorders and chronic pain 
[16, 20]. 
Duloxetine leads to an increase in serotonin and noradrenaline levels in the 
presynaptic neuron in Onuf's nucleus in the sacral spinal cord by inhibiting their re-uptake. 
Stimulation of neurons located in the Onuf's nucleus by serotonin and noradrenaline leads to 
an increase in the closure pressure of the urethral sphincter muscle and strengthens its 
tension, which reduces the symptoms of stress urinary incontinence [19, 20]. 
Duloxetine affects the patient as long as it is administered. It does not completely cure 
stress urinary incontinence, but only alleviates its symptoms. The treatment with Duloxetine 
may be associated with side effects, most often nausea, to which elderly people are 
particularly vulnerable. Other adverse effects of the drug include dizziness, tiredness, dry 
mouth, constipation and excessive sweating, which are a frequent reason for ceasing 
pharmacotherapy [17, 18, 20]. For this reason, treatment should be started with a low dose 
and be increased gradually, with regular control every 2-4 weeks to assess the tolerability of 
the drug. According to the recommendation of the International Urogynecological 
Association, treatment should begin with a dose of 20 mg twice a day for 2 weeks, with a 
target dose increase to 40 mg twice daily [12, 17]. 
Duloxetine is approved for use in the European Union, but due to the possibility of 
side effects such as toxic impact on the liver and suicidal ideations, it was withdrawn from 
use in the US [16, 19, 20]. 
According to the The National Institute for Health and Care Excellence (NICE) 
guidelines, Duloxetine is therefore not recommended as first-line treatment, but only as 
second-line therapy for women who are not classified or do not want to undergo surgery [17, 
20]. 
 
Physiotherapy in stress urinary incontinence 
Physical therapy as well as kinesiotherapy, also known as motion treatment are the 
pillars of physiotherapy in treating stress urinary incontinence. In recent years, there has been 
an increase in the level of knowledge of women about SUI and the possibilities of its 
treatment. Due this reason urogynecological physiotherapy has undergone an intensive 
development. Physical therapy treatments used in SUI includes electrostimulation, 
magnetotherapy and magnetostimulation as well as vibro-therapy, which in recent years has 
become an increasingly popular method of supporting SUI treatment [5]. 
The electric current in the treatment of urinary incontinence was first used in 1965. 
For over 50 years, many studies have been carried out to explain the mechanism of impact of 
electrical stimulation on the pelvic structures. It was found that in addition to the direct effect 
of stimulating the muscles to contraction, electrostimulation also restores the proper 
positioning of the bladder neck. Electrostimulation also affects the remodeling of muscles, 
affecting their resistance to fatigue, or the possibility of having a longer contraction. 
However, the effectiveness of the therapy depends on at least partial innervation of the pelvic 
floor. Muscle spasm determines correctly preserved micturition arch. One of the possibilities 
of SUI treatment with the use of electric current is intra-vaginal electrostimulation requiring 
placement of the probe – an electrode, in the vagina. It is recommended when the patient's 
response to the stimulation is delayed and the spasm is poorly felt. The treatment improves 
blood circulation and strengthens the muscles, thus allowing better urinary retention. External 
stimulation uses medium-frequency current, and it requires placing one electrode directly 
above the pubic symphysis and the other on the back around the anus. Correia et al. 
conducted a clinical trial in which they compared the effectiveness of external and internal 
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electrostimulation in the treatment of SUI. All patients showed a significant reduction in 
uncontrolled micturition episodes and a significant improvement in the quality of life [21, 
22].  
In physiotherapy, the magnetic field is widely used in many disease entities. Its 
biological activity is very complex. The magnetic wave permeates all the body's structures, 
and the changes take place at the cellular and tissue level. It affects the process of cellular 
respiration, increases activity of some enzymes and protein synthesis. It also affects the 
structure of collagen, which plays an important role in the correct mechanism of micturition 
in older women. The procedure is fully comfortable for patients. They are sitting fully 
dressed in a chair, which has a built-in magnetic field generator. Unsal et al. Evaluated the 
effectiveness of magnetic field stimulation in patients with SUI. They performed the 
procedure for 8 weeks twice a week, for 20 minutes, with a frequency of 5Hz in the first 10 
minutes, and in the second half 50 Hz. A year after the end of the therapy, 38% of patients 
had been completely cured and 41% had a significant improvement. In addition to PFM 
stimulation, there is a possibility of using nerve root stimulation S2-S4 in treating urinary 
incontinence. Both Fujishiro et al. And Manganotti et al. used this method in their clinical 
tests, and had very good effects of therapy. In both experiments, the parameters were similar, 
a frequency of 15 Hz was used, the treatment was repeated 2 or 3 times a week for a 
minimum duration of time of 2 weeks. These studies showed a significant improvement in 
the quality of life of patients after the first week of therapy [23,24,25]. 
 Vibrotherapy is a non-invasive and well-tolerated method supporting SUI treatment. 
In 2007 Sønksen together with colleagues conducted a clinical trial using vibrations in which 
participated 29 women with SUI. Stimulation of perineal nerves was applied once a week for 
6 weeks. After completion of the study, 24 women were cured and 5 improved their condition 
[26,27]. 
 Currently, the most common treatment for both conservative and symptomatic SUI 
are the so-called Kegel exercises, consisting of the voluntary contraction of the levator ani 
muscle and the pubal muscles. According to different authors of the research, 12% to 60% of 
women undergo a cure or an improvement after Kegel therapy. Pelvic Floor Muscle Training 
(PFMT) is based on conscious tightening and loosening of selected muscle groups, aimed at 
functional elongation of the urethra, activation of periarticular muscles, creating a better 
support of the urinary bladder. It is recommended to do exercises at least twice a day for 10 
minutes, which should give at least 200 contractions at one day. Patients should also contract 
their muscles at the load, i.e. when coughing, going up the stairs. However, the healing 
success depends in a large extent on the regularity, discipline and perseverance in performing 
the exercises daily in a proper way [5,28]. 
In addition to physical methods and kinesitherapy in the treatment of SUI, a 
physiotherapist can also apply a healing massage. The aim of the massage is normalization of 
the tension of the ligament apparatus, located in the bladder area and improvement of the 
sphincter function. But not only that, massage can also restore the proper distribution of the 
lymph and venous blood of the bladder region. Local bladder development widens the blood 
vessels of the massaged body area, thereby oxygenating, nourishing and regenerating the 
cells. As a result of elasticity, it improves the firmness and ability of muscles to contract and 
relax, including the bladder sphincter muscles [29]. 
 
Surgical treatment of stress urinary incontinence 
When the behavioral and pharmacological treatment does not bring the desired 
effects, surgical treatment should be instituted [30]. Despite many operational possibilities 
(types of treatments) up to 20% of them may fail [31]. As we know, stress urinary 
incontinence is caused by two reasons. The first is the increased mobility of the urethra, most 
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often resulting from the defect of the pubic-urethral ligament which stabilizes the urethra and 
the other is the internal dysfunction of the sphincter. By generalizing all invasive procedures, 
they try to eliminate these disorders. 
Operative methods can be roughly divided into Colposuspension, mainly using the 
Burch method, which can be carried out in an open or laparoscopic way, whereas the 
experience of the operator in the case of a laparoscopic solution is crucial for the results of 
treatment, and MUS methods (retropubic sling, single incision sling and transobturator sling), 
it is also possible to use artificial sphincter.  The review of methods shows a high variation in 
the availability of treatment methods, whereas there is no coherence in the indication of the 
best surgical method in stress urinary incontinence in women. 
Consideration of the methods of surgical treatment in stress urinary incontinence 
should be started with the least invasive method, which is the injection of bulking agents. 
This method involves injecting the substance into the peri-ligation area, as a result of which 
the volume of the coil sphincter increases. The substances can be injected via the abdominal 
wall, through the urethral path, or introduced laterally from the urethra. We obtain an 
expanding effect that supports the work of an inefficient urethral sphincter. An undoubted 
advantage of this low-invasive method is the operation under local anesthesia, it can be 
performed in outpatient settings, and the patient goes home shortly after this procedure [32]. 
The effectiveness of this method and the undesirable effects of this method vary depending 
on the materials used for injection. In the case of collagen (glutaraldehyde cross-linked 
collagen), 10-23% of respondents were cured, the condition improved in 52-57.9%, where the 
results are 2-year results. Side effects were mainly urinary retention, obstruction of urination 
in 15% of respondents [33, 34]. In the case of carbon-coated zirconium beads (carbon coated 
zirconium beads), two-year effects gave a cure of 19-33% [35]. There are also other 
substances such as calcium hydroxyapatites or cross-linked polydimethylsiloxane that give 
similar results to the above-mentioned substances. It should also be remembered that the 
therapeutic effect decreases over the years, and most of these substances require re-injection 
of the urethra [32]. 
The surgical method of first-line stress urinary incontinence is MUS (midurethral 
sling), but it is also suitable for women whose first operation was unsuccessful. It involves 
placing the tape behind the urethra, at the moment of increased pressure inside the abdominal 
cavity (cough, laughter) the tape provides support for the coil so that urine can not get out of 
it. We distinguish two main types of this operation: RPMUS-retropubic and TMUS-
transobturator. Many studies have proved similar effectiveness of both methods in long-term 
and short-term effects, while one of the arguments for the TMUS method is a smaller number 
of complications and pain sensations, and also shorter stay in the hospital after running the 
TMUS method. The percentage of cure for TMUS ranged from 62% to 98% and in the 
RPMUS group from 71% to 97% at the end of 1 year. In the long-term, subjective healing 
ranged from 43% to 92% in the TMUS group and from 51% to 88% in the RPMUS group. 
There are also modifications of major MUS subtypes such as mini-sling, while numerous 
studies show that mini-sling in which self-adjusting ends were used to minimize the risk of 
damage to vessels and nerves gives worse results compared to the traditional method [36, 37, 
38, 39].  
Another method of SUI treatment is a colposuspension which can be carried out in an 
open or laparoscopic manner. The use of a laparoscope leads to a shortening of the patient's 
stay in the hospital and its recovery. the mechanism of the operation consists in affixing the 
pubis-coil fascia and the adjacent urethral fascia to the Cooper's ligament using a prolene 
mesh. The effectiveness of the burch's method is 81% on a scale of 1 year [40]. One clinical 
trial compared the effectiveness of this method compared to MUS. The results showed 47% 
of the overall MUS contention compared to 38% of the burcha method. However, a smaller 
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number of complications, urinary stasis and urinary tract infections speak in favor of 
colposuspension [41, 42]. However, if we compare the open method of burcha to 
laparoscopic results after 1, 2 and 3-5 years are similar, in favor of the open surgery speaks 
the mean shorter time of the procedure (47 minutes compared to 87 minutes 
laparoscopically). The laparoscopic method was associated with less blood loss, less pain and 
faster recovery after surgery [43, 44]. 
Another interesting method of SUI treatment in particularly advanced cases is the use 
of an artificial urethral sphincter (AUS). It is not a popular method and it is only developing 
in many centers in the world. The difficult development of this case results in the fact of a 
short urethra which could lead to an increased amount of infections about the insertion of an 
artificial sphincter [45]. this is the final method in SUI when other surgical interventions have 
failed [46]. Currently, the first long-term 10-20-year results appear in which the effectiveness 
of AUS is 84% [47]. 
 
Discussion  
Modern data on stress urinary incontinence have repeatedly underlined the difficulty 
in performing daily activities by persons suffering from the mentioned disease. There are 
more and more recent studies to better understand the extent to which stress urinary 
incontinence affects individual elements of everyday life, as well as to develop newer 
methods of functioning despite the presence of the ailment. An example of this was a 
questionnaire distributed via e-mail about the impact of urinary incontinence on quality of 
life. 605 women who are US citizens who suffer from incontinence responded to the 
questions. According to the results of the study mentioned, the presence of stress urinary 
incontinence is felt as embarrassing, which was confirmed by over three-quarters of the 
respondents. However, 29% of the surveyed women considered the disorder to be highly 
troublesome or embarrassing to an extreme extent. At the same time, a correlation was 
demonstrated, according to which inconveniences related to incontinence increase with the 
age of the respondents [4], which confirms the assumption of our work, emphasizing the 
great importance of the problem of urinary incontinence in older women. 
The topic of urinary problems in older women was taken in a 3-year prospective 
cohort study at the University of Leicester (UK), examining the issue together with people 
suffering from an overactive bladder. A total of 2,052 women aged over 40 participated in the 
project. Performing appropriate urological diagnostics, it has been shown that the presence of 
an overactive bladder definitely increases the risk of stress urinary incontinence. The 
assumptions formulated in our work were also confirmed that the incidence of incontinence 
increases with age. At the same time, two periods have been noted where the risk is 
particularly high: one at the age of about 60 years and the other at the age of about 80 [48]. A 
similar study, however, including a group of women at a more advanced age (70-79 years) 
was conducted at the University of California (USA). A cross-sectional analysis of 1,584 
white and black women was conducted there, leading a long-term cohort study. According to 
him, 21% of women in the study observed urinary incontinence over the last week. Among 
them, stress urinary incontinence occurred as often as sporadic. Among many factors 
increasing the risk of urinary incontinence, which were observed during the analysis, 
attention was paid to: belonging to the Caucasian race, diabetes, occurrence of depression or 
estrogen intake [49]. These factors should therefore be taken into account when planning 
further research into the disease under consideration, as well as defining the rules of conduct 
in clinical practice. 
As mentioned in our review, physiotherapy and physical exercise is an important part 
of the treatment of stress urinary incontinence. However it often turns out that carrying out 
physical activity while incontinence may be difficult. Realizing this fact, older women 
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commonly avoid any physical effort over the fear of the urinating against their will. To 
confirm whether women really avoid physical activity, an email survey of 5,130 women aged 
18-60 was sent, in which questions about the discomfort associated with urinary incontinence 
during the physical exercise were formulated. 3364 women (68% of respondents) answered 
questions, of which 1 in 7 subjects experience urinary incontinence caused by physical 
exertion. Also, disturbances in urination in women exercising more often and more 
intensively were also more frequently observed. For 9.8% of the respondents, the mere 
presence of the disorder in question was a barrier to practicing physical activity [50], which 
means a considerable difficulty in introducing treatment with methods of physical exercise, 
limited by human consciousness. Therefore, actions should be taken to promote specific 
physical exercises, the effectiveness of which to reduce the discomfort associated with stress 
urinary incontinence has already been confirmed. Pelvic muscle exercises, which can reduce 
the symptoms of the disease by up to 90%, seem to be ideal here. The effectiveness of such 
exercises has also been confirmed for older women [51]. 
 
Conclusions 
Stress urinary incontinence (SUI) is more and more common in the population, 
mainly in women. SUI refers to more than 5% of society and affects the quality of life of 
people affected by it, which according to the definition of WHO allows SUI to be granted the 
status of a social disease.  
There are many risk factors such as weight, age, hormonal dysfunctions, and also 
many pathomechanisms of this disease. In pharmacological treatment the only licensed drug 
used in the treatment of SUI of which efficiency has been confirmed in randomized 
controlled clinical trials is Duloxetine - a serotonin-noradrenaline reuptake inhibitor (SNRI).  
Which leads to an increase in the closure pressure of the urethral sphincter muscle and 
strengthens its tension, which reduces the symptoms of stress urinary incontinence  Available 
scientific and medical reports indicate the therapeutic effect of physiotherapeutic treatments 
in the disorder in question. Currently, the most common treatment for both conservative and 
symptomatic SUI are the so-called Kegel exercises, consisting of the voluntary contraction of 
the levator ani muscle and the pubal muscles. Physical therapy concludes electrotherapy, 
magnetic field therapy. In addition to physical methods and kinesitherapy in the treatment of 
SUI, a physiotherapist can also apply a healing massage. 
Physiotherapeutic activities and pharmacological treatment should be an integral parts 
of a holistic approach to the patient and his treatment plan. 
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